Junmin Zhou

2.0k total citations
55 papers, 1.5k citations indexed

About

Junmin Zhou is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Junmin Zhou has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Surgery and 14 papers in Immunology. Recurrent topics in Junmin Zhou's work include Immune cells in cancer (7 papers), Breast Lesions and Carcinomas (6 papers) and Breast Cancer Treatment Studies (6 papers). Junmin Zhou is often cited by papers focused on Immune cells in cancer (7 papers), Breast Lesions and Carcinomas (6 papers) and Breast Cancer Treatment Studies (6 papers). Junmin Zhou collaborates with scholars based in United States, China and Taiwan. Junmin Zhou's co-authors include Xianghong Chen, Julie Y. Djeu, Erika A. Eksioglu, Eric T. Gugger, Nicole Fortenbery, Sheng Wei, Danielle L. Gilvary, Sarah S. Donatelli, Sheng Wei and George L. Blackburn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Junmin Zhou

53 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junmin Zhou United States 19 539 528 447 270 206 55 1.5k
Jianlin Qiao China 20 612 1.1× 371 0.7× 402 0.9× 135 0.5× 89 0.4× 108 1.6k
Zhao‐Yang Lu China 23 779 1.4× 366 0.7× 439 1.0× 387 1.4× 103 0.5× 64 1.7k
Jianghong Wu China 23 901 1.7× 180 0.3× 317 0.7× 379 1.4× 116 0.6× 49 1.6k
Carl Whatling Sweden 23 383 0.7× 223 0.4× 174 0.4× 247 0.9× 74 0.4× 44 1.5k
Raffaele Di Francia Italy 20 337 0.6× 157 0.3× 363 0.8× 129 0.5× 198 1.0× 66 1.1k
Zhiqiang Ning China 19 1.0k 1.9× 206 0.4× 417 0.9× 266 1.0× 128 0.6× 41 1.4k
Stefano Manarini Italy 22 485 0.9× 420 0.8× 179 0.4× 107 0.4× 97 0.5× 36 2.1k
Vanessa Innao Italy 20 642 1.2× 216 0.4× 453 1.0× 155 0.6× 63 0.3× 60 1.3k
Elisabeth Koller Austria 23 481 0.9× 312 0.6× 257 0.6× 159 0.6× 108 0.5× 75 1.7k
Jie Huang China 23 577 1.1× 159 0.3× 340 0.8× 231 0.9× 104 0.5× 97 1.4k

Countries citing papers authored by Junmin Zhou

Since Specialization
Citations

This map shows the geographic impact of Junmin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmin Zhou more than expected).

Fields of papers citing papers by Junmin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junmin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmin Zhou. The network helps show where Junmin Zhou may publish in the future.

Co-authorship network of co-authors of Junmin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Junmin Zhou. A scholar is included among the top collaborators of Junmin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junmin Zhou. Junmin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Junmin, Songlin Wan, Chun Guang Li, et al.. (2023). Retroperitoneal abscess as a presentation of colon cancer: The largest case set analysis to date, which extracted from our unit and the literature. Frontiers in Oncology. 13. 1198592–1198592.
2.
3.
Bulls, Hailey W., Naomi C. Brownstein, Junmin Zhou, et al.. (2021). Patient‐reported symptom burden in routine oncology care: Examining racial and ethnic disparities. Cancer Reports. 5(3). e1478–e1478. 29 indexed citations
4.
Kim, Dae Won, Elaine Tan, Junmin Zhou, et al.. (2021). A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer. British Journal of Cancer. 124(11). 1803–1808. 28 indexed citations
5.
Kim, Youngchul, Junmin Zhou, Roger Li, et al.. (2020). Positive Ki-67 and PD-L1 expression in post-neoadjuvant chemotherapy muscle-invasive bladder cancer is associated with shorter overall survival: a retrospective study. World Journal of Urology. 39(5). 1539–1547. 11 indexed citations
6.
Sun, James, Brittany Mathias, Weihong Sun, et al.. (2020). Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?. Annals of Surgical Oncology. 28(1). 320–329. 19 indexed citations
7.
Sweet, Kendra, Rami S. Komrokji, Eric Padron, et al.. (2019). Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia. Clinical Cancer Research. 26(1). 54–60. 22 indexed citations
8.
DePeralta, Danielle K., Takuya Ogami, Junmin Zhou, et al.. (2019). Completion of adjuvant therapy in patients with resected pancreatic cancer. HPB. 22(2). 241–248. 31 indexed citations
9.
Al‐Toubah, Taymeyah, Michael J. Schell, Mauro Cives, et al.. (2019). A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms. Neuroendocrinology. 110(5). 377–383. 12 indexed citations
10.
11.
Azizi, Mounsif, Dominic H. Tang, Daniel Verduzco, et al.. (2018). Impact of PI3K-AKT-mTOR Signaling Pathway Up-regulation on Prognosis of Penile Squamous-Cell Carcinoma: Results From a Tissue Microarray Study and Review of the Literature. Clinical Genitourinary Cancer. 17(1). e80–e91. 17 indexed citations
12.
O’Donoghue, Cristina, Weihong Sun, Junmin Zhou, et al.. (2017). Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer. Journal of Surgical Research. 215. 55–59. 7 indexed citations
13.
Zhou, Junmin, Xianghong Chen, Danielle L. Gilvary, et al.. (2015). HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells. Scientific Reports. 5(1). 15085–15085. 43 indexed citations
14.
Chen, Xianghong, Erika A. Eksioglu, John D. Carter, et al.. (2015). Inactivation of DAP12 in PMN Inhibits TREM1-Mediated Activation in Rheumatoid Arthritis. PLoS ONE. 10(2). e0115116–e0115116. 14 indexed citations
15.
Wu, Jinfeng, Jinhua Xu, Erika A. Eksioglu, et al.. (2013). Icariside II Induces Apoptosis of Melanoma Cells Through the Downregulation of Survival Pathways. Nutrition and Cancer. 65(1). 110–117. 28 indexed citations
16.
Zhou, Junmin, Jinfeng Wu, Xianghong Chen, et al.. (2011). Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. International Immunopharmacology. 11(7). 890–898. 129 indexed citations
17.
Wu, Jinfeng, Junmin Zhou, Xianghong Chen, et al.. (2011). Attenuation of LPS-induced inflammation by ICT, a derivate of icariin, via inhibition of the CD14/TLR4 signaling pathway in human monocytes. International Immunopharmacology. 12(1). 74–79. 38 indexed citations
18.
Ren, Chen, Kimberly Nicholson, Domenico Coppola, et al.. (2008). Combined IL-8 and TGF-β blockade efficiently prevents neutrophil infiltrates into an A549-cell tumor. Immunology Letters. 122(1). 26–29. 6 indexed citations
19.
Zhou, Junmin, et al.. (2007). Rhabdastrellic acid‐A inhibited PI3K/Akt pathway and induced apoptosis in human leukemia HL‐60 cells. Cell Biology International. 32(1). 48–54. 16 indexed citations
20.
Wei, Sheng, Junmin Zhou, Jinhong Liu, et al.. (2007). The zebrafish activating immune receptor Nitr9 signals via Dap12. Immunogenetics. 59(10). 813–821. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianlin Qiao Breakdown of academic impact, for papers by Zhao‐Yang Lu Breakdown of academic impact, for papers by Jianghong Wu Breakdown of academic impact, for papers by Carl Whatling Breakdown of academic impact, for papers by Raffaele Di Francia Breakdown of academic impact, for papers by Zhiqiang Ning Breakdown of academic impact, for papers by Stefano Manarini Breakdown of academic impact, for papers by Vanessa Innao Breakdown of academic impact, for papers by Elisabeth Koller Breakdown of academic impact, for papers by Jie Huang
Rankless by CCL
2026